Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
An experimental solution could buy time for transplant patients.
Embryonic tissue could let xenotransplants evade the host’s immune system.
The results could be an initial step toward generating viable, transplantable human organs.
Rising levels of donor DNA in recipients’ blood could mean the organ is in danger.
Unhealthy organs provide a framework for growing replacement ones.